A new study indicates that severity of amyloid deposition in the brain -; not just age -; may be key to determining who will benefit from new anti-amyloid therapies to delay the progression of Alzheimer’s disease.
IFNγ identified as crucial for reducing pulmonary viral loads in COVID-19, new research shows
The role of type-2 interferon (IFNγ) in antiviral immunity.